0
Title
User
LIVE NOW
LIVE NOW
Title
User
Schedule An Interview
Schedule A Remote Interview with OncologyTube
Home
Trending
Sign In
Audios and Videos
Videos
Audios
Channels
Browse Channels
Categories
Acute Lymphoblastic Leukemia
5648
Acute Myelogenous Leukemia
202
Bladder Cancer
71
Bone Metastases
2
Brain Cancer
59
Breast Cancer
233
Business Management
3
Cervical Cancer
6
Chronic Lymphocytic Leukemia
192
Chronic Myelogenous Leukemia
43
Colorectal Cancer
110
COVID-19
27
Gastrointestinal Cancer
93
General
320
Head and Neck Cancers
74
Hematologic Malignancies
180
Hodgkin Lymphoma
28
Immunotherapy
155
Kidney Cancer
376
Liver Cancer
25
Lymphoma
180
Melanoma and Skin Cancer
57
Multiple Myeloma
466
Myeloproliferative Disease
20
News
148
Non-Hodgkin Lymphoma
77
Non-Small Cell Lung Cancer
413
Other
256
Ovarian Cancer
43
Pancreatic Cancer
73
Patient Resources
28
Pediatric Cancer
3
Prostate Cancer
225
Sickle Cell
21
Small Cell Lung Cancer
72
Soft Tissue Sarcoma
10
Supportive Care
47
Testicular Cancer
3
Urology
14
Uterine Cancer
7
About
Contact
00:07:21
Updated Results on PACIFIC Trial: Should we Revise Who Should Receive Consolidation Immunotherapy after Chemo/Radiation? (BMIC-065)
Dr. Jack West discusses the trial design of the PACIFIC trial of consolidation durvalumab (Imfinzi) after chemo/radiation for unresectable stage III NSCLC and highlights new data on overall survival and the different results in patient subgroups.
262 Views
2 years ago
BeaconMedIC
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
Suggested
Trending
0:05:57
Response to Anti–PD-1/PD-L1 Antibody Immunotherapy @CleClinicMD
Free
92 Views
1 year ago
Cleveland Clinic
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
00:00:35
Cancer Immunotherapy: how to predict results better
Free
83 Views
1 year ago
Melwy
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
00:01:07
IMDC Classification Role in Treatment Decision-Making
Free
149 Views
1 year ago
obr
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
00:01:36
Clinical Trials on the Use of I-O and TKIs in RCC
Free
33 Views
1 year ago
obr
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
1
(current)
2
3
4
5
6
7
8
9
10
Immunotherapy
00:16:41
Geoffrey M. Lowman, PhD @thermofisher #Immunotherapy #Oncology #TCRSequencing #Cancer #Research Haplotype Analysis of the TCRB Locus by Long-amplicon TCRB Repertoire Sequencing
Free
92 Views
3 weeks ago
cancernewsupdate
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
00:09:38
Tito R. Mendoza, PhD, MS, MEd @MDAndersonNews #Immunotherapy #Cancer #Research Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory
Free
14 Views
3 weeks ago
Cancer-News
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
00:10:32
Daniel Catenacci, MD @DocCatenacci @UChicagoMed #immunotherapy #cancer #research Phase 2 Expansion Cohorts for its Personalized Neoantigen Immunotherapy GRANITE
Free
18 Views
3 months ago
Cancer-News
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
00:04:09
Jacob Adashek, DO @jacobadashek @USouthFlorida @MoffittNews @Dr_R_Kurzrock @AlexeyGoloubev #SITC20 #carcinomas Immunotherapy trials lack a biomarker for inclusion: implications for drug d...
Free
44 Views
3 months ago
SITC
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
0:13:55
Jennifer Baker Flechtner, Ph.D. @GenoceaBio #AACR #immunotherapy Reveal New Understanding of ATLASTM-Identified InhibigenTM Biology
Free
21 Views
5 months ago
AACR
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
0:06:09
Sigrun Hallmeyer, MD @ACCCBuzz #immunotherapy Immuno-Oncology and What Lies Ahead
Free
31 Views
5 months ago
Cancer-News
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
0:03:48
Jacob J. Adashek, DO @MoffittNews @ASCO20 Targetable immune checkpoint molecules may be significantly differentially expressed in minority ethnicities.
Free
47 Views
5 months ago
Cancer-News
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
0:05:19
Jared Gollob @JaredGollob @KymeraTx #AACR20 What's the Advantage of IRAK4 Combined into One Molecule
Free
11 Views
5 months ago
Cancer-News
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
0:05:17
Jared Gollob @JaredGollob @KymeraTx #AACR20 IRAKIMiD Degrader Program and Present Preclinical Data Demonstrating Potent Immunomodulatory and Antitumor Activity for its Novel STAT3 Degraders
Free
27 Views
5 months ago
Cancer-News
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
0:01:30
Antibody based redirection of meditope CAR-T cells selectively kill antigen bearing tumor cells - In Closing - John Williams Ph.D. - City of Hope @cityofhope #cartcells #CAR-T
Free
18 Views
5 months ago
Cancer-News
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
0:02:32
Antibody based redirection of meditope CAR-T cells selectively kill antigen bearing tumor cells - Will this affect clinicians - John Williams Ph.D. - City of Hope @cityofhope #cartcells #...
Free
18 Views
5 months ago
Cancer-News
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
0:01:52
Antibody based redirection of meditope CAR-T cells selectively kill antigen bearing tumor cells - Common Questions - John Williams Ph.D. - City of Hope @cityofhope #cartcells #CAR-T
Free
16 Views
5 months ago
Cancer-News
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
1
(current)
2
3
4
5
6
7
8
9
10